Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Indaptus Therapeutics, Inc. (INDP) had Cash Flow from Financial Activities of $3.15M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.53M |
|
-- |
|
-- |
|
$4.57M |
|
$-4.57M |
|
$0.04M |
|
$-4.53M |
|
$-4.53M |
|
$-4.53M |
|
$-4.53M |
|
$-4.53M |
|
$-4.53M |
|
$-4.57M |
|
$-4.57M |
|
14.10M |
|
14.10M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$4.96M |
|
-- |
|
$0.45M |
|
$5.41M |
|
$2.61M |
|
-- |
|
-- |
|
$2.61M |
|
$2.80M |
|
$2.80M |
|
$2.80M |
|
16.03M |
|
| Cash Flow Statement Financials | |
$-5.05M |
|
-- |
|
|
Cash Flow from Financial Activities |
$3.15M |
$5.79M |
|
$3.89M |
|
$-1.90M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-161.89% |
|
-161.89% |
|
-83.75% |
|
-161.89% |
|
$0.17 |
|
$-0.36 |
|
$-0.36 |
|